What role will the Opportunities List will play in the Critical Path Initiative?
The purpose of the Opportunities List is to provide concrete focus for public and private efforts and investments in new tools that could revolutionize product development. The long-anticipated announcement of the Critical Path Opportunities List signals the next vital step in the agency’s Critical Path Initiative aimed at modernizing medical product development to deliver smart medical care that is personalized, predictive and preventive. The list outlines an initial 76 “science projects” to bridge the gap between the quick pace of new biomedical discoveries and the slow pace at which those discoveries are currently translated into therapies for patients. The release of the list marks a starting point in identifying the essential development priorities to be accomplished under the agency’s Critical Path Initiative. Experts estimate, if accomplished, the new tests and tools developed under the Critical Path Initiative will modernize the drug development process by 2010 and help to get
